Minireviews
World J Hepatol
9(25):1043-1053.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1043
Abstract (797)
|
Core Tip (813)
|
Full Article (HTML) (3064)
|
Tables (1-3) (174)
|
Full Article (PDF)-1379K (509)
|
Audio-718K (14)
|
Peer-Review Report-94K (140)
|
Answering Reviewers-128K (151)
|
Received: 05/27/2017
|
Revised: 07/13/2017
|
Accepted: 08/04/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (9816)
|
Similar Articles (363)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
9(25):1054-1063.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1054
Abstract (901)
|
Core Tip (728)
|
Full Article (HTML) (3573)
|
Full Article (PDF)-1369K (660)
|
Audio-468K (12)
|
Peer-Review Report-78K (198)
|
Answering Reviewers-64K (138)
|
Received: 01/26/2017
|
Revised: 07/18/2017
|
Accepted: 08/16/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (11092)
|
Similar Articles (177)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Hepatol
9(25):1064-1072.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1064
Abstract (947)
|
Core Tip (751)
|
Full Article (HTML) (3980)
|
Figures (1-2) (179)
|
Tables (1-2) (174)
|
Full Article (PDF)-1444K (306)
|
Audio-2584K (14)
|
Peer-Review Report-98K (131)
|
Answering Reviewers-81K (107)
|
Received: 03/16/2017
|
Revised: 05/17/2017
|
Accepted: 07/17/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (9)
|
Total Visits (13014)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Hepatol
9(25):1073-1080.
Published online Sep 8, 2017.
doi: 10.4254/wjh.v9.i25.1073
Abstract (777)
|
Core Tip (702)
|
Full Article (HTML) (2771)
|
Figures (1-3) (184)
|
Tables (1-2) (177)
|
Full Article (PDF)-1721K (353)
|
Audio-547K (21)
|
Peer-Review Report-82K (100)
|
Answering Reviewers-134K (108)
|
Received: 01/04/2017
|
Revised: 04/29/2017
|
Accepted: 05/24/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12581)
|
Similar Articles (111)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open